FDA approves Dupixent (dupilumab) to treat eczema starting at 6 months old | Carrick Pharmacy
(Carrick Pharmacy News) The US Food and Drug Administration (FDA) has approved a new eczema treatment for kids. This is the first biologic medicine for kids (aged 6 months to 5 years) with moderate to severe atopic dermatitis (eczema). This new approval is found under the name Dupixent (dupilumab). It is available as an injection …
